Nourish Raises $100M Series C as Investors Eye Post-GLP-1 Plays Nourish, a telehealth platform that pairs patients with registered dietitians, comes as more people take weight-loss drugs but struggle with what comes next Nourish, a New York-based virtual nutrition clinic, has closed a $100 million Series C led by Menlo Ventures, bringing total funding to $215 million in just over four years
Meanwhile, a food database allows for calorie and macronutrient tracking
Balance between metallothionein and metal response element binding transcription factor 1 is mediated by zinc ions (review)
Clinical efficacy : Large randomised controlled trials demonstrate that GLP-1 receptor agonists can reduce HbA1c by approximately 1.01.5% and produce weight loss of 515% of body weight, with the higher end of weight loss typically seen with higher-dose semaglutide (2.4mg/Wegovy) specifically for obesity treatment
Comparison to Existing Treatments: Effectiveness, Safety, And Accessibility Evaluating the effectiveness, safety, and accessibility of new treatment modalities in comparison to traditional therapies is essential in assessing their potential impact
